Accuray signs development and supply agreement with medPhoton

2 May 2016 (Last Updated May 2nd, 2016 18:30)

US-based radiation oncology company, Accuray, has signed an agreement with Austrian radiotherapy medical imaging company medPhoton to partner on integrating the ImagingRing system with the CyberKnife System.

Imagingring

US-based radiation oncology company, Accuray, has signed an agreement with Austrian radiotherapy medical imaging company medPhoton to partner on integrating the ImagingRing system with the CyberKnife System.

The long-term strategic agreement is expected to provide Accuray with certain exclusive development, sales and distribution rights of the ImagingRing for use in adaptive radiation therapy, stereotactic body radiation therapy (SBRT) and robotic radiosurgery.

medPhoton founder and CEO Heinz Deutschmann said: "The partnership with Accuray provides us with the opportunity to integrate our leading-edge imaging technology with the CyberKnife System, one of the industry's most advanced treatment delivery systems.

"We believe the products will complement each other and enable clinicians to truly optimise the radiation treatments they can provide their patients."

"We believe the products will complement each other and enable clinicians to truly optimise the radiation treatments they can provide their patients."

ImagingRing system enables a range of advanced imaging capabilities including large field-of-view cone beam CT in a photon and ion beam therapy.

It features two arms carrying X-ray source and flat panel detector mounted on a ring which is composed of strong aluminium-alloy allowing reproducible and completely independent movement of the imaging components along the ring.

The CyberKnife M6 Series is designed for radiosurgery and stereotactic body radiation therapy enabling precise, high-quality and accurate dose distributions to patients requiring lesser number of treatments while reducing side effects and improving patient's quality of life.

The system can adjust and automatically stay on target in real-time, tracking the patient and tumour motion continually throughout the treatment.


Image: A 6D skull tracking done by Cyberknife system. Photo: courtesy of Steven3045.